Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19

      Clinical Trials
      Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This open-label study evaluated 5-day...

      Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre

      Drug Development
      Oxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the Vaccines Manufacturing and Innovation...

      Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO in Multiple Myeloma

      Clinical Trials
      Takeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the European Hematology Association (EHA)....

      Covance launches COVID-19 clinical trial matching platform

      Clinical Trials
      The drug development firm has introduced COVID-19 Clinical Trial Connect, a site designed to help potential patients match with research studies. Covance, the drug development...

      Johnson & Johnson moves up COVID-19 vaccine trial to second half of July

      Clinical Trials
      Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of...

      Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

      FDA Approvals
      Kite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization from the EMA for...

      Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

      Drug Development
      Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.